214 related articles for article (PubMed ID: 6118432)
1. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
[No Abstract] [Full Text] [Related]
2. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
[No Abstract] [Full Text] [Related]
3. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
Mattsson H; Hedberg A; Carlsson E
J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
[TBL] [Abstract][Full Text] [Related]
4. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
Rohm N; Wagner J; Schümann HJ
Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
[TBL] [Abstract][Full Text] [Related]
5. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
Coulombe D
Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
[TBL] [Abstract][Full Text] [Related]
6. Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity.
Kenakin TP
J Cardiovasc Pharmacol; 1985; 7(1):208-10. PubMed ID: 2580145
[No Abstract] [Full Text] [Related]
7. Basic pharmacological properties of prenalterol.
Mattsson H; Hedberg A; Carlsson E
Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
[No Abstract] [Full Text] [Related]
8. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
[No Abstract] [Full Text] [Related]
9. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
[TBL] [Abstract][Full Text] [Related]
10. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
11. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
Kenakin TP; Beek D
J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
[TBL] [Abstract][Full Text] [Related]
12. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
[No Abstract] [Full Text] [Related]
13. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
Vincent HH; Boomsma F; Man in't Veld AJ; Derkx FH; Wenting GJ; Schalekamp MA
J Cardiovasc Pharmacol; 1984; 6(1):107-14. PubMed ID: 6199591
[TBL] [Abstract][Full Text] [Related]
14. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
Johansson U; Waldeck B
J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
[TBL] [Abstract][Full Text] [Related]
15. [New drugs with positive inotropic action].
Bijak A; Czołpiński T
Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
[No Abstract] [Full Text] [Related]
16. Responses mediated via beta-1 adrenoceptors but not beta-2 adrenoceptors exhibit supersensitivity after chronic reserpine pretreatment.
Grassby PF; Broadley KJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):950-8. PubMed ID: 3012076
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
[TBL] [Abstract][Full Text] [Related]
20. On the stereospecificity of the beta2-adrenoceptor blocking properties of prenalterol.
Johansson U; Waldeck B
J Pharm Pharmacol; 1980 Sep; 32(9):659-60. PubMed ID: 6107373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
